INTECH Investment Management’s Damora Therapeutics DMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,505
Closed -$247K – 1582
2026
Q2
$247K Buy
+9,505
New +$230K ﹤0.01% 1682

Other funds holding DMRA

INTECH Investment Management's DMRA Position: Q3 2026 in Review

INTECH Investment Management sold out of Damora Therapeutics (DMRA) in Q3 2026, closing a stake of 9,505 shares — an estimated $247K sold.

INTECH Investment Management first reported a position in DMRA in Q2 2026 and held it in 1 quarter. The position peaked at $247K in Q2 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

  • INTECH Investment Management reported no remaining Damora Therapeutics position as of Q3 2026 after selling out during the quarter.
  • INTECH Investment Management sold 9,505 Damora Therapeutics shares in Q3 2026, an estimated $247K.
  • INTECH Investment Management first reported a position in Damora Therapeutics in Q2 2026 and held it in 1 quarter.
  • INTECH Investment Management's Damora Therapeutics position peaked at $247K in Q2 2026.
  • 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.